The Research Department at Salugen investigates a wide range of scientific activity from genetic associations with diseases, nutritional intake and supplementation, and the synergies of nutrients with pharmacogenomic research. Salugen scientists bring over 30 years of research into the genetic and nutritional factors influencing many common healthcare concerns. These scientists currently focus their efforts on healthcare conditions that involve the brain and heredity.

Published Studies

Salugen scientists have played an important role in defining the market of nutrigenomics and pharmacogenomics. In addition, there are thousands of publications supporting the genes and nutrients involved in Salugen products.  Despite these publications, there is still a significant need for more research.  There are studies supporting the genes and studies supporting the ingredients but, as for the link between the genes and the nutrients, there are only a small number of randomized, double-blinded, placebo-controlled studies to support these correlations.  Salugen is committed to furthering this research.

Future Clinical Studies

Salugen is committed to investing 20 percent of its sales into research and development to bring new technologies to market, and conduct clinical studies to demonstrate their safety and efficacy. Currently, Salugen has several clinical studies planned with additional investigations in the early stages of development.

Research Links and Resources

From the National Institutes of Health

Overviews

Related Issues

Newsletters/Print Publications

Genetics

Research

Dictionaries/Glossaries

Directories

Organizations

Law and Policy

Children

Women